Key facts
- Notable investors include TopoScend Capital, Shanghai Zhonghuijin Investment Group, Changsha Chang Xin Investment Management, Hangzhou Taiheng Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Jiajiale BioTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Jiajiale BioTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jiajiale BioTech
Developer of synthetic biotechnology products intended for protein production through advanced biological engineering. The company offers methods for protein design, strain selection, fermentation engineering, and related biotechnologies, supplying strains, enzymes, and other functional materials that can be applied across cosmetics, pharmaceuticals, and food manufacturing, enabling industry users to advance research and development practices within their operational environments.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2020
- Website
- jajalebiotech.com/
- Ownership
- Privately Held (backing)
Jiajiale BioTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jiajiale BioTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jiajiale BioTech in its N-PORT filings yet. We sweep new filings monthly.